The Paris Colon Cancer Congress 2026 (P3C) is an international congress focused on advancing multidisciplinary and patient-centered colorectal cancer care. The program will cover early-onset, localized, and metastatic disease, immunotherapy, biomarkers, treatment sequencing, survivorship, quality of life, equity, and access to care.

Through expert sessions, clinical debates, multidisciplinary discussions, and patient perspectives, P3C aims to support practical strategies that improve colorectal cancer care and outcomes worldwide.

Who Should Attend?

P3C is designed for oncologists, surgeons, gastroenterologists, pathologists, researchers, oncology nurses, pharmacists, patient advocates, healthcare leaders, and other professionals involved in colorectal cancer care and research.

Why To Attend?

Participants will gain practical insights into current standards, emerging evidence, and challenging areas of colorectal cancer management. The congress will also offer opportunities to learn from international experts, multidisciplinary teams, and patient representatives.